Looking Beyond Overall Survival: FDA-AACR Workshop Explored Novel Oncology Endpoints
A workshop hosted by AACR and FDA explored novel clinical trial oncology endpoints and considerations for their validation and...
A workshop hosted by AACR and FDA explored novel clinical trial oncology endpoints and considerations for their validation and...
Elizabeth M. Jaffee, Timothy R. Rebbeck, and Andrea Cercek spoke about the AACR's conference on the rise of early-onset...
Researchers highlighted AI's potential to enhance clinical cancer care, including to improve diagnosis, guide precision medicine, and more.
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.
This post examines ultraprocessed foods and what current research shows about how they impact health and cancer risk.
A study suggests that modifying a patient’s gut microbiome could make their cancer more likely to respond to CAR...
At the AACR Annual Meeting 2025, experts offered strategies on how to overcome the challenges within the oncology drug...
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving...
Learn how a Gleason score is calculated to help determine the aggressiveness of prostate cancer, and how it could...
At the AACR Annual Meeting 2025, a session on artificial intelligence in cancer care included ways of detecting skin...